Suppr超能文献

无功能垂体大腺瘤中高催乳素血症的患病率。

The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas.

作者信息

Zhang Fangfang, Huang Yinxing, Ding Chenyu, Huang Guoliang, Wang Shousen

机构信息

Department of Endocrinology, First Hospital of Fuzhou Affiliated to Fujian Medical University Fuzhou 350009, China.

Department of Neurosurgery, Fuzhou General Hospital of Nanjing Command, PLA Fuzhou 350025, China.

出版信息

Int J Clin Exp Med. 2015 Oct 15;8(10):18990-7. eCollection 2015.

Abstract

OBJECTIVE

The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas (NFPMAs) is not well known, and hyperprolactinemia caused by a NFPMA is currently associated with diagnostic uncertainty. Thus, the aim of this study was to evaluate the prevalence of hyperprolactinemia in NFPMAs.

METHODS

A meta-analysis of all existing articles in PubMed was conducted. The search string was designed as "(non-functioning pituitary tumor OR non-functioning pituitary tumor OR non-functioning pituitary macroadenomas OR non-functioning pituitary macroadenomas OR non-functioning pituitary adenomas OR non-functioning pituitary adenomas) and hyperprolactinemia". References of the articles found were also reviewed. Study selection and data extraction were performed independently by two reviewers. Data were analyzed with STATA 11.0 software (StataCorp LP, USA). The fixed effects model was used to evaluate these studies.

RESULTS

The search identified 57 published studies, seven of which were accepted for the final meta-analysis. The authors found an overall estimated 40.2% prevalence of (95% CI, 36.6%-43.7%) hyperprolactinemia in NFPMAs.

CONCLUSIONS

Given the high frequency of hyperprolactinemia in NFPMAs, a diagnosis of NFPMA or prolactinoma should be made more carefully.

摘要

目的

无功能垂体大腺瘤(NFPMAs)中高泌乳素血症的患病率尚不清楚,且由NFPMAs引起的高泌乳素血症目前与诊断不确定性相关。因此,本研究的目的是评估NFPMAs中高泌乳素血症的患病率。

方法

对PubMed中所有现有文章进行荟萃分析。搜索词设计为“(无功能垂体瘤或无功能垂体肿瘤或无功能垂体大腺瘤或无功能垂体大腺瘤或无功能垂体腺瘤或无功能垂体腺瘤)和高泌乳素血症”。还对所发现文章的参考文献进行了审查。研究选择和数据提取由两名审阅者独立进行。使用STATA 11.0软件(美国StataCorp LP公司)进行数据分析。采用固定效应模型对这些研究进行评估。

结果

检索到57项已发表的研究,其中7项被纳入最终的荟萃分析。作者发现NFPMAs中高泌乳素血症的总体估计患病率为40.2%(95%可信区间,36.6%-43.7%)。

结论

鉴于NFPMAs中高泌乳素血症的发生率较高,对NFPMAs或泌乳素瘤的诊断应更加谨慎。

相似文献

引用本文的文献

3
Prolactinoma: Clinical Characteristics, Management and Outcome.催乳素瘤:临床特征、管理与结局
Cureus. 2022 Oct 2;14(10):e29822. doi: 10.7759/cureus.29822. eCollection 2022 Oct.
4
Speed of response to dopaminergic agents in prolactinomas.泌乳素瘤对多巴胺能药物的反应速度。
Endocrine. 2022 Mar;75(3):883-888. doi: 10.1007/s12020-021-02953-1. Epub 2021 Nov 30.

本文引用的文献

8
Nonfunctioning pituitary adenomas: the Oxford experience.无功能垂体腺瘤:牛津大学的经验
Nat Rev Endocrinol. 2009 Sep;5(9):519-22. doi: 10.1038/nrendo.2009.147.
10
Hyperprolactinemia.高催乳素血症
Pituitary. 2008;11(2):141-6. doi: 10.1007/s11102-008-0107-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验